Ken Griffin Zomedica Corp. Transaction History

Citadel Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.12 - $0.18 $35,967 - $53,950	-299,725 Reduced 40.33%	443,382 $66,000
Q1 2024 May 15, 2024	SELL	$0.12 - $0.19 $8,818 - $13,963	-73,490 Reduced 9.0%	743,107 $111,000
Q4 2023 Feb 14, 2024	BUY	$0.15 - $0.22 $122,489 - $179,651	816,597 New	816,597 $163,000
Q2 2023 Aug 14, 2023	BUY	$0.19 - $0.22 $14,038 - $16,255	73,889 New	73,889 $14,000
Q3 2022 Nov 14, 2022	SELL	$0.2 - $0.38 $5,430 - $10,318	-27,153 Reduced 63.36%	15,705 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.34 $357,642 - $607,992	-1,788,212 Reduced 97.66%	42,858 $9,000
Q1 2022 May 16, 2022	BUY	$0.28 - $0.4 $345,706 - $493,866	1,234,666 Added 207.02%	1,831,070 $617,000
Q4 2021 Feb 14, 2022	SELL	$0.31 - $0.58 $26,339 - $49,280	-84,967 Reduced 12.47%	596,404 $184,000
Q3 2021 Nov 15, 2021	SELL	$0.46 - $0.81 $616,170 - $1.08 Million	-1,339,500 Reduced 66.28%	681,371 $357,000
Q1 2021 May 17, 2021	BUY	$0.35 - $2.7 $449,168 - $3.47 Million	1,283,339 Added 174.0%	2,020,871 $3.19 Million
Q4 2020 Feb 16, 2021	BUY	$0.07 - $0.25 $51,627 - $184,383	737,532 New	737,532 $170,000

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.